PharmaCyte Names Joshua Silverman Interim CEO As CEO Kenneth Waggoner Steps Down

RTTNews | 978 dias atrás
Stocktwits
PharmaCyte Names Joshua Silverman Interim CEO As CEO Kenneth Waggoner Steps Down

(RTTNews) - Biotechnology company PharmaCyte Biotech, Inc. (PMCB) announced Friday that its CEO Kenneth Waggoner has stepped down from the position as CEO, effective October 6, 2022. The Board has since appointed Joshua Silverman, a member of the Board, as interim CEO.

Silverman is currently a director of PharmaCyte and the Co-Founder and Managing Member of Parkfield Funding LLC and is a former Principal and Managing Partner of Iroquois Capital Management, LLC.

He served as Co-Chief Investment Officer of Iroquois from 2003 until July 2016. From 2000 to 2003, he served as Co-Chief Investment Officer of Vertical Ventures, LLC, a merchant bank.

Prior to forming Iroquois, Silverman was a Director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously, he served as Assistant Press Secretary to The President of The United States.

The company also announced that its Board of Directors has empowered its Business Review Committee to evaluate opportunities to realize optimal shareholder value.

Etiquetas: PMCB
Stocktwits
read more
European Economic News Preview: UK GDP, Foreign Trade Data Due

European Economic News Preview: UK GDP, Foreign Trade Data Due

Monthly GDP, industrial production and foreign trade from the UK are due on Thursday, headlining a light day for the European economic news. At 2.00 am ET, the Office for National Statistics releases UK GDP, industrial production and foreign trade figures. The economy is forecast to shrink 0.1 percent on a monthly basis in April, reversing a 0.2 percent rise in March.
RTTNews | 1 h 59 min atrás
Sensex, Nifty Subdued In Cautious Trade

Sensex, Nifty Subdued In Cautious Trade

Indian shares were subdued on Thursday as investors assessed U.S. President Donald Trump's declaration that a trade deal with China was "done" and that he would set unilateral tariff rates for trading partners within two weeks.
RTTNews | 2 h 15 min atrás
Australian Market Doubles Early Gains In Mid-market

Australian Market Doubles Early Gains In Mid-market

The Australian market is doubling its early gains in mid-market moves on Thursday, extending the gains in the previous two sessions, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,600 level, with gains in gold miners and energy stocks partially offset by weakness in iron ore miners.
RTTNews | 2 h 39 min atrás
Asian Markets Trade Mixed

Asian Markets Trade Mixed

Asian stock markets are trading mixed on Thursday, following the broadly negative cues from Wall Street overnight, after US President Donald Trump said he and Chinese President Xi Jinping "are going to work closely together to open up China to American Trade." However, signs of escalating geopolitical tensions in the Middle East are weighing on market sentiment.
RTTNews | 3 h 30 min atrás
Ferramentas
Calendário Económico
Market Hours
Interest Rates
Holidays Calendar
Mercado Forex
Volatilidade Forex
Correlação Forex
Notícias Forex
forex analysis
Dados COT
Liquidez
Calculadoras Forex
Mapa de Calor Forex
Indicators Heatmap
Comunidade
Comunidade
Sistemas
Sistemas Mais Populares
Estratégias
Concursos
Gráficos Forex
Sentimento Forex
Indicador do Outlook
Avaliações
Brokers
Prop Trading Firms
Serviços VPS
Provedores de Sinais
Serviços de Programação EA
Affiliate Programs
Serviços de Corretores PAMM
Serviços de Programa de Descontos
Plataformas de Negociação
Consultores Especialistas
Trocas Crypto
Trading Courses
Brokers
Forex Spreads
Cotações do Corretor Forex
Swaps de Corretor Forex
Volume do Corretor Forex
Promoções Corretor Forex Press Release
Plataforma
Widgets
Recursos
API
RSS
Stock Portfolio
Affiliate Software
Gráficos Avançados
Apoio
FAQ
Ajuda
Contacte-Nos
Reportar um erro!
Sobre
Blog
© 2025 Myfxbook Ltd Todos os Direitos Reservados.
AVISO DE ALTO RISCO: A negociação em moeda estrangeira comporta um alto nível de risco que pode não ser adequado para todos os investidores. A vantagem cria risco adicional e exposição a perdas. Antes de decidir negociar em moeda estrangeira, considere cuidadosamente os seus objetivos de investimento, nível de experiência e tolerância ao risco. Pode perder parte ou todo o seu investimento inicial. Não invista dinheiro que não possa perder. Eduque-se sobre os riscos associados à negociação em moeda estrangeira e procure aconselhamento de um consultor financeiro ou fiscal independente se tiver alguma dúvida. Quaisquer dados e informações são fornecidos apenas para fins informativos e não se destinam a fins comerciais ou de consultoria. O desempenho anterior não é indicativo de resultados futuros.